Sign in

You're signed outSign in or to get full access.

Eric D. Tanzberger

Director at Sanara MedTech
Board

About Eric D. Tanzberger

Eric D. Tanzberger, age 56, is an independent director of Sanara MedTech Inc. (SMTI) since 2022. He serves as Executive Vice President and Chief Financial Officer of Service Corporation International (SCI) and previously was SCI’s SVP & CFO (2006–2024), with prior roles including Corporate Controller; he began his career at Coopers & Lybrand. He holds a BBA from the University of Notre Dame and is designated by SMTI’s board as an “audit committee financial expert.”

Past Roles

OrganizationRoleTenureCommittees / Impact
Service Corporation International (SCI)Executive Vice President & Chief Financial Officer2024–presentSenior finance leadership; responsibilities expanded to include IT in 2022
Service Corporation International (SCI)Senior Vice President & Chief Financial Officer; Treasurer (2007–2017)2006–2024 (CFO)Led finance, treasury functions
Service Corporation International (SCI)Corporate Controller2002Corporate accounting leadership
Coopers & Lybrand LLPFinancial services (early career)N/APublic accounting experience

External Roles

OrganizationRoleTenureNotes
United Way of Greater HoustonExecutive Committee of the Board of Trustees; Audit Committee ChairOngoingNon-profit governance and audit oversight

Board Governance

  • Independence: The board determined that Tanzberger is independent under Nasdaq rules.
  • Committee assignments: Audit Committee (Chair); Corporate Development Committee (Member).
  • Financial expertise: Designated as an “audit committee financial expert.”
  • Attendance: In 2024, each director attended at least 75% of total board and committee meetings; all eight directors attended the 2024 annual meeting.
  • Meeting cadence (2024): Board (4); Audit (4); Compensation (6); Nominating & Governance (6); Corporate Development (4).
  • Lead Independent Director: None; the board maintains a combined Executive Chairman/CEO structure.

Fixed Compensation (Director)

Component (2024 service cycle)DetailEvidence
Annual cash retainer$0 (retainers paid in equity)Non-Employee Director Compensation table shows $0 cash for directors
Equity retainer (time-vested RS)3,768 shares; intended value $115,000; grant date June 12, 2024; vests June 12, 2025Grant program and counts/values disclosed ; vesting timing
Reported stock award grant-date value$117,825 (ASC 718)Director compensation table
Committee chair/member feesIncorporated into equity through policy (Audit Chair +$20k; committee member +$5k)Director equity policy: board $90k; Audit Chair $20k; committee member $5k; all payable in restricted stock
Meeting feesNone disclosed

Performance Compensation

  • SMTI does not provide performance-based (metric-driven) equity or cash to non-employee directors; director compensation consists of annual restricted stock retainers that vest with service. No performance metrics or targets disclosed for director pay.

Other Directorships & Interlocks

CategoryDetail
Current public company boardsNone disclosed for Tanzberger beyond SMTI
Private/non-profit boardsUnited Way of Greater Houston (Exec Committee; Audit Chair)
Potential interlocks/conflictsNone disclosed involving Tanzberger; audit committee (which he chairs) oversees related-party transactions

Expertise & Qualifications

  • Audit committee financial expert with extensive CFO experience at a large public company (SCI).
  • Deep financial reporting, internal controls, risk oversight and IT responsibility (SCI responsibilities broadened to IT in 2022).
  • Company policy prohibits hedging, short sales, options trading, and pledging of company stock without prior CEO/CFO approval, supporting alignment and risk mitigation.

Equity Ownership

MetricAmount/Detail
Total beneficial ownership (4/11/2025)14,068 shares (<1% of outstanding)
Unvested restricted stock included3,768 RS; vests June 12, 2025
OptionsNone disclosed for Tanzberger
Shares pledgedNo pledging disclosed; policy restricts pledging absent pre-approval
Shares outstanding (for context)8,887,984 (as of 4/11/2025)

Governance Assessment

  • Positives:
    • Independent director and Audit Committee Chair with “audit committee financial expert” designation—strong signal for financial oversight and internal control rigor.
    • Equity-only director compensation with clear vesting schedule aligns director incentives with shareholder value; no cash retainers or meeting fees.
    • Board and committee engagement appear adequate given 2024 meeting cadence and ≥75% attendance threshold met by all directors.
  • Watch items:
    • No Lead Independent Director; Executive Chairman and CEO roles combined—may raise independence optics, although board maintains majority-independent composition.
    • Related-party transactions at the company (Catalyst, Rochal) are overseen by the audit committee; none involve Tanzberger based on disclosures, but ongoing oversight remains important. -
  • Shareholder feedback context:
    • 2023 say-on-pay received strong support (For 5,548,532; Against 24,489; Abstain 888; Broker Non-Votes 1,791,319), indicating general investor confidence in compensation governance at that time.

Notes:

  • All details reflect SMTI’s 2025 Definitive Proxy and related filings. Where not disclosed (e.g., director-specific attendance %, insider trades, ownership guidelines), items are omitted consistent with filings. -